0
0
Massachusetts's General Hospital Study Demonstrates Prevencio's AI-driven HART CVE Blood Test Highly Accurate for Predicting Major Cardiac Events in Patients with Chronic Kidney Disease - Business Wire
11/3/22 at 6:32pm
Organization
Business Wire
51 words
0
Comments
Prevencio, Inc. today announces the presentation of patient data demonstrating its Artificial Intelligence (AI)-driven HART CVE blood test is highly a
You are the first to view
https://www.businesswire.com/news/home/20221103006259/en/Massachusetts%E2%80%99s-General-Hospital-Study-Demonstrates-Prevencio%E2%80%99s-AI-driven-HART-CVE-Blood-Test-Highly-Accurate-for-Predicting-Major-Cardiac-Events-in-Patients-with-Chronic-Kidney-Disease
Create an account or login to join the discussion